Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SURAJ CHOPRA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1235512005
CMS profile
8799793
Location
ALTOONA, PA

General Payments · PY2021–2024

$310.74

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$299.00

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $299.00 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $11.74 1
PY2024 $299.00 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $13.64 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104734209 CMS
AstraZeneca Pharmaceuticals LP $14.34 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105717195 CMS
AstraZeneca Pharmaceuticals LP $16.14 10/23/2024 Food and Beverage Undisputed 01/23/2026 1104595344 CMS
E.R. Squibb & Sons, L.L.C. $15.92 04/10/2024 Food and Beverage Undisputed 01/23/2026 1101680600 CMS
E.R. Squibb & Sons, L.L.C. $21.08 06/20/2024 Food and Beverage Undisputed 01/23/2026 1101680607 CMS
E.R. Squibb & Sons, L.L.C. $21.08 08/05/2024 Food and Beverage Undisputed 01/23/2026 1101680632 CMS
E.R. Squibb & Sons, L.L.C. $18.82 09/10/2024 Food and Beverage Undisputed 01/23/2026 1101680643 CMS
Janssen Pharmaceuticals, Inc $20.38 04/23/2024 Food and Beverage Undisputed 01/23/2026 1078145123 CMS
Janssen Pharmaceuticals, Inc $17.69 05/23/2024 Food and Beverage Undisputed 01/23/2026 1078145101 CMS
Janssen Pharmaceuticals, Inc $20.24 08/30/2024 Food and Beverage Undisputed 01/23/2026 1078145065 CMS
Novartis Pharmaceuticals Corporation $23.40 09/13/2024 Food and Beverage Undisputed 01/23/2026 1086781807 CMS
Novartis Pharmaceuticals Corporation $21.06 10/17/2024 Food and Beverage Undisputed 01/23/2026 1086781811 CMS
Novartis Pharmaceuticals Corporation $23.40 11/21/2024 Food and Beverage Undisputed 01/23/2026 1086781815 CMS
PFIZER INC. $17.81 11/19/2024 Food and Beverage Undisputed 01/23/2026 1130999272 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 1153666312 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.96 12/11/2024 Food and Beverage Undisputed 01/23/2026 1153548241 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.